Stock data
Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD) reported revenue of US$29.44B and net income of US$8.51B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$29.44B | — | US$10.02B | US$8.51B | — |
| 2024 | US$28.75B | — | US$1.66B | US$480.00M | — |
| 2023 | US$27.12B | — | US$7.61B | US$5.67B | — |
| 2022 | US$27.28B | — | US$7.33B | US$4.59B | — |
| 2021 | US$27.30B | — | US$9.92B | US$6.22B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$7.80B | -US$10.50B | — |
| 2026-03-31 | US$6.96B | US$2.02B | — |
| 2025-12-31 | US$7.92B | US$2.18B | — |
| 2025-09-30 | US$7.77B | US$3.05B | — |
| 2025-06-30 | US$7.08B | US$1.96B | — |
| 2025-03-31 | US$6.67B | US$1.31B | — |
| 2024-12-31 | US$7.57B | US$1.78B | — |
| 2024-09-30 | US$7.54B | US$1.25B | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.